Indian Journal of Pharmacy Practice volume 12, issue 3 cover
Search this issue

Cover: Indian Journal of Pharmacy Practice

Indian Journal of Pharmacy Practice

Volume 12, Issue 3

2019 · pp. 154–214 · 12 articles

Volume
12
Issue
3
Published
2019
Pages
154–214
Articles
12
Sections
4
ISSN
Online - 0974-8326
Journal
IJOPP

In this issue

Editorial

  1. Forum Article

    Rabia Hussain, Mohamed Azmi Hassali, Isha Patel

    pp. 154–155 · DOI: 10.5530/ijopp.12.3.34 · 2019

    The notorious Nipah virus is again in action in India and in May 2018 it has took 19 lives in Indian states named Kerala and Karnataka.1 A total of 19 cases have been reported to be under treatment for the virus.1 The si…

Review Article

  1. Review

    Purnima Ashok, Blessy Maria Thomas

    pp. 156–160 · DOI: 10.5530/ijopp.12.3.35 · 2019

    G6PD Deficiency is considered as the most frequently seen enzymopathy affecting the erythrocytes. It has high prevalence rates in the regions of tropical Africa, the Middle East, tropical and subtropical Asia. Severe G6P…

Research Article

  1. Article

    Shiv Kumar, G. Madhuri, Anju Wilson, Tigi S George

    pp. 161–166 · DOI: 10.5530/ijopp.12.3.36 · 2019

    Background:Chronic obstructive pulmonary disease, a common preventable and treatable disease has been a major public health problem in this century and is one of the leading causes of morbidity and mortality in the indus…

  2. Article

    Kamal Saini, Rajveer Singh, Divyani Agrawal

    pp. 167–170 · DOI: 10.5530/ijopp.12.3.37 · 2019

    Background:Pregnancy is the most vulnerable condition prone for anemia (most commonly iron deficiency anemia). Hence requires drug therapy for iron store replenishment. Comparing the safety between ferrous carboxymaltose…

  3. Article

    Praisy Johnson, Sasubilli Lavanya, Jisin Abraham, Githa Kishore

    pp. 171–175 · DOI: 10.5530/ijopp.12.3.38 · 2019

    Background: Globally the quality of life (QOL) among the elderly is deteriorating. Therefore, it should be considered as an important aspect to improve their health and wellbeing. Objectives:To assess the quality of life…

  4. Article

    Meshwa Soni, Rutul Patel, Komal Patel, Janki Patel, Shrikalp Deshpande

    pp. 176–187 · DOI: 10.5530/ijopp.12.3.39 · 2019

    Background:Antibacterials are the most imperative weapons in our hands, accounting for the majority of ambulatory care prescriptions. Irrational use of antibiotics in developing countries like India have led to emergence…

  5. Article

    Hanan Mohammed Al Yousef, Syed Wajid, Ibrahim Sales

    pp. 188–193 · DOI: 10.5530/ijopp.12.3.40 · 2019

    Background and Objectives:Herbal products are widely used in many countries in various forms including roots, leaves, barks seeds and so many, for inhibiting and treating Number of minor and major disorders. The purpose …

Case Report

  1. Article

    Milovan Stojanović, Sonja Stojanović, Jovan Nedović, Slađana Božilov

    pp. 194–197 · DOI: 10.5530/ijopp.12.3.41 · 2019

    Bakers cyst is synovial cyst that is located in popliteal fossa. Rupture of meniscus and inflammatory diseases of synovial joints are the most common cause of Bakers cyst. Cyst diagnosis is based on a clinical picture, t…

  2. Article

    Mahek Mistry, Vikas R. Chandrakar, Hemraj Singh Rajput

    pp. 198–201 · DOI: 10.5530/ijopp.12.3.42 · 2019

    Escitalopram is a selective serotonin reuptake inhibitor (SSRI) and S-enantiomer of racemic escitalopram, enhances serotonergic activity in the central nervous system (CNS). It is indicated for the Major depressive disor…

  3. Article

    Anisha Thomas, Raima Roy, Akhila S Arjun

    pp. 202–204 · DOI: 10.5530/ijopp.12.3.43 · 2019

    Cushing’s syndrome is a rare endocrine disorder that comprises a large group of signs and symptoms resulting from chronic exposure to excess cortisol, a hormone that adrenal gland produces and corticosteroids. Most cases…

  4. Article

    Satyavardhan Rao Nittu, Akhila D

    pp. 205–208 · DOI: 10.5530/ijopp.12.3.44 · 2019

    Consequences of inappropriate medication use have been the subject of professional, public and congressional discourse from ages. The pharmacy profession has accepted responsibility for providing patient education and co…

  5. Article

    Swati Jadhav, Ravindra Ghooi

    pp. 209–214 · DOI: 10.5530/ijopp.12.3.45 · 2019

    The government notified the New Drugs and Clinical Trial Rules on 19th March 2019, to replace Part XA and Schedule Y of the Drugs and Cosmetics Rules 1945. Many new desirable changes have been made and these will help cl…